Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study-Reference-Cited by-同舟云学术

Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study

Published:2024-08 Issue:8 Volume:11 Page:e580-e592
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Locatelli Franco,Antmen Bulent,Kang Hyoung Jin,Koh Katsuyoshi,Takahashi Yoshiyuki,Kupesiz Alphan,Dias Matos Maria Gabriela A,Chopra Yogi,Bhat Sunil,Im Ho Joon,Güngör Tayfun,Lu Meng-Yao,Stefanelli Tommaso,Rosko Christine,St Pierre Annie,Burock Karin,Smith Yvonne,Sinclair Karen,Diaz-de-Heredia Cristina

Publisher

Elsevier BV

Reference19 articles.

1. Acute graft-versus-host disease;Malard;Nat Rev Dis Primers,2023

2. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report;Jagasia;Biol Blood Marrow Transplant,2015

3. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice;Greinix;Biol Blood Marrow Transplant,2011

4. Long-term morbidity and mortality in children with chronic graft-versus-host disease classified by National Institutes of Health consensus criteria after allogeneic hematopoietic stem cell transplantation;Inagaki;Biol Blood Marrow Transplant,2015

5. Failure-free survival after initial systemic treatment of chronic graft-versus-host disease;Inamoto;Blood,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruxolitinib: a game changer in paediatric chronic graft-versus-host disease management?;The Lancet Haematology;2024-08